The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
you know as as you pointed out a diabetes doctor never used to see a child in their careers that had diabetes now we've dropped the early onset diabetes label it's so common among kids that's actually happening more and more with Alzheimer's we're about to drop probably the early onset Alzheimer's it's just keeps going down down down because dementias Downstream in many cases according to a lot of research of insulin resistance abut and diabetes
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.